Sobos articles on GLP-1 weight loss plateaus, GLP-1 muscle loss, food noise, and what happens after GLP-1 weight loss all connect to the same principle: medical weight loss is not only about access to medication
Orforglipron, developed by Eli Lilly, is the first non-peptide oral GLP-1 agonist, achieving up to 1.8% HbA1c reduction and 1012% body-weight loss in Phase 3 trials
This summer, wanting to shed fat and gain muscle, he sought out retatrutide, a next-generation GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor agonista triple agonist targeting appetite, blood sugar, and metabolism
Her knowledge unparalleled
Tirzepatide has a half-life of approximately 5 days
Ive had personal trainers and Ive had to let them go because they just wanted to do three sets of And they kept starting me on such low weight